These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8555788)

  • 1. Platelet count and platelet factor 3 (PF-3) availability in sickle cell disease.
    Famodu AA; Oduwa D
    Br J Biomed Sci; 1995 Dec; 52(4):323-4. PubMed ID: 8555788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation during steady state sickle cell disease.
    Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
    J Med; 1983; 14(1):17-36. PubMed ID: 6224876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor XIII concentration in sickle-cell disease.
    Ittyerah R; Alkjaersig N; Fletcher A; Chaplin H
    J Lab Clin Med; 1976 Oct; 88(4):546-54. PubMed ID: 965808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet P-selectin expression in patients with sickle cell disease who undergo apheresis.
    Boga C; Ozdogu H; Kozanoglu I; Sozer O; Sezgin N; Kizilkilic E; Bakar C
    Ther Apher Dial; 2007 Aug; 11(4):255-61. PubMed ID: 17661830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet function in patients with sickle cell anaemia in Nairobi.
    Maina JM; Aluoch JR
    East Afr Med J; 1996 Sep; 73(9):568-70. PubMed ID: 8991234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of reticulated platelets in patients with sickle cell diseases.
    Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
    Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of platelet activation in sickle cell anaemia.
    Ibanga IA
    Niger J Med; 2006; 15(2):148-50. PubMed ID: 16805172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine profile of sickle cell disease in Oman.
    Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
    Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
    Liem RI; O'Gorman MR; Brown DL
    Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic activity in adult Kenyan patients with sickle cell disease.
    Aluoch JR
    East Afr Med J; 1998 Jun; 75(6):351-2. PubMed ID: 9803619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
    Ahmed S; Siddiqui AK; Iqbal U; Sison CP; Shahid RK; Sheth M; Patel DV; Russo LA
    Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet factor 3 activity in Plasmodium falciparum malaria.
    Emuchay CI; Usanga EA
    East Afr Med J; 1997 Aug; 74(8):527-9. PubMed ID: 9487421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation and physiological anticoagulants in sickle-cell disease.
    Bashawri LA; Al-Mulhim AA; Ahmed MA; Bahnassi AA
    East Mediterr Health J; 2007; 13(2):266-72. PubMed ID: 17684847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a metabolic shift of arginine metabolism in sickle cell disease.
    Schnog JJ; Jager EH; van der Dijs FP; Duits AJ; Moshage H; Muskiet FD; Muskiet FA
    Ann Hematol; 2004 Jun; 83(6):371-5. PubMed ID: 15054669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis.
    Papadimitriou CA; Travlou A; Kalos A; Douratsos D; Lali P
    Acta Haematol; 1993; 89(4):180-3. PubMed ID: 8212998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood rheology abnormalities and vascular cell adhesion mechanisms in sickle cell trait carriers during exercise.
    Connes P; Hue O; Tripette J; Hardy-Dessources MD
    Clin Hemorheol Microcirc; 2008; 39(1-4):179-84. PubMed ID: 18503123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease.
    Amin MA; Amin AP; Kulkarni HR
    Ann Hematol; 2004 Jun; 83(6):331-5. PubMed ID: 15052371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
    Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
    Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients.
    Enosolease ME; Ejele OA; Awodu OA
    Niger Postgrad Med J; 2005 Jun; 12(2):102-5. PubMed ID: 15997258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The older sickle cell patient.
    McKerrell TD; Cohen HW; Billett HH
    Am J Hematol; 2004 Jun; 76(2):101-6. PubMed ID: 15164373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.